POM-V Prescription Required

Tilmovet 250 mg/ml Concentrate for Oral Solution for Pigs, Chickens, Turkeys and Cattle (Calves)

Active ingredient: Tilmicosin

Form

Liquid

Species

Cattle Chickens Pigs Turkeys

Manufacturer

Huvepharma N.V.

VMD MA No.

30282/5023

What it's used for

before the veterinary medicinal product is used. Chickens: For the treatment and prevention of respiratory infections in poultry flocks associated with Myc...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tilmicosin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Tilmovet 250 mg/ml Concentrate for Oral Solution for Pigs, Chickens, Turkeys and Cattle (Calves) — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

before the veterinary medicinal product is used.
Chickens:
For the treatment and prevention of respiratory infections in poultry flocks associated
with Mycoplasma gallisepticum and Mycoplasma synoviae. The presence of the
disease in the herd must be established before the veterinary medicinal product is
used.
Turkeys: For the treatment and prevention of respiratory infections in turkey flocks
associated with Mycoplasma gallisepticum and Mycoplasma synoviae. The presence
of the disease in the herd must be established before the veterinary medicinal product
is used.
Cattle (calves): For the treatment and prevention of respiratory infections associated
with Mannheimia haemolytica, P. multocida, Mycoplasma bovis and M.dispar. The
AN: 03998/2023 and 03999/2023Page 2 of 7
presence of the disease in the herd must be established before the veterinary
medicinal product is used.

milk replacer before administration.
AN: 03998/2023 and 03999/2023Page 4 of 7
To ensure a correct dosage, body weight should be determined as accurately as
possible. The intake of medicated water depends on the clinical condition of the
animals. In order to obtain the correct dosage the concentration of tilmicosin may need
to be adjusted accordingly.
Pigs:
15-20 mg tilmicosin per kg body weight for 5 days, i.e. 6-8 ml of veterinary medicinal
product for 100 kg body weight corresponding to 80 ml of veterinary medicinal product
per 100 litres of drinking water for 5 days.
Chickens (broilers and pullets):
15-20 mg tilmicosin per kg body weight for 3 days, i.e. 6-8 ml of veterinary medicinal
product for 100 kg body weight corresponding to 30 ml of veterinary medicinal product
per 100 litres of drinking water for 3 days.
Turkeys:
10-27 mg tilmicosin per kg body weight for 3 days, i.e. 4-11 ml of veterinary medicinal
product for 100 kg body weight corresponding to 30 ml of veterinary medicinal product
per 100 litres of drinking water for 3 days.
Calves:
12.5 mg tilmicosin per kg body weight two times per day for 3-5 days, i.e. 1 ml of
veterinary medicinal product for 20 kg body weight two times per day for 3-5 days.
One 960 ml bottle is sufficient to medicate 1200 litres of drinking water for pigs or 3200
litres of drinking water for broilers, turkeys and pullets.
One 960 ml bottle is sufficient to medicate drinking water or milk replacer for 48 – 80
calves (40 kg b.w.).
One 240 ml bottle is sufficient to medicate drinking water or milk replacer for 8 calves
(60 kg b.w.).
Medicated drinking water should be prepared fresh every 24 hours using only clean
water.
Medicated milk replacer should be prepared fresh every 4 hours using only clean
water.
If signs of disease do not significantly improve within 3-5 days, the diagnosis should
be re-evaluated and treatment changed.
Do not administer to pigs in a wet feeding system.

Do not administer to ruminating animals with active rumen function.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not allow horses or other equines access to drinking water containing tilmicosin.
Horses fed with water containing tilmicosin may present signs of toxicity with lethargy,
anorexia, reduction of feed consumption, loose stools, colic, distension of the
abdomen and death.

Chickens (broilers and pullets), turkeys, pigs and cattle (calves):
Very rare (<1 animal / 10,000
animals treated, including isolated
reports)
Decreased drinking
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Tilmicosin should not be administered by injection to pigs. The veterinary medicinal
product contains disodium edetate. The uptake of medicated water can be altered as a
consequence of illness. If the uptake is insufficient alternative treatment may be
required.
Repeated use of the veterinary medicinal product should be avoided by improving
management practices and thorough cleansing and disinfection.
Cross-resistance has been shown between tilmicosin and other macrolides (like
tylosin, erythromycin) or lincomycin. Use of the veterinary medicinal product should be
carefully considered when susceptibility testing has shown resistance to other
macrolides or lincosamides because its effectiveness may be reduced.

Special precautions for safe use in the target species:
Do not use when there is resistance to tilmicosin or cross resistance to other
macrolides (like tylosin, erythromycin) or lincomycin.
Inappropriate use of the veterinary medicinal product may increase the prevalence of
bacteria resistant to tilmicosin and may decrease the effectiveness of treatment with
tilmicosin related substances.
Use of the veterinary medicinal product should be based on identification and
susceptibility testing of the target pathogen(s). If this is not possible, therapy should be
based on epidemiological information and knowledge of susceptibility of the target
pathogens at farm level, or at local/regional level.
Use of the veterinary medicinal product should be in accordance with official, national
and regional antimicrobial policies.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach.
AN: 03998/2023 and 03999/2023Page 3 of 7
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to tilmicosin should avoid contact with the
veterinary medicinal product. The veterinary medicinal product may cause irritation or
sensitisation by skin contact.
Avoid skin and ocular contact. Personal protective equipment consisting of protective
gloves and protective clothes should be worn when handling the veterinary medicinal
product.
Do not eat, drink or smoke when handling this product.
In case of contact with skin or eyes, rinse abundantly with fresh water. If irritation
persists and in case of accidental ingestion, seek medical advice immediately and
show the package leaflet or the label to the physician, or call a poison centre (dangers
linked to disturbances in cardiac conduction).
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.

Tilmicosin may lessen the antibacterial activity of β-lactam antibiotics
Do not use simultaneously with bacteriostatic antimicrobial agents.

As packaged for sale: Do not store above 30°C. Protect from frost. Protect from light.
After dilution in drinking water / milk replacer: Protect from light.

Meat and offal:
Pigs: 14 days
Cattle (calves): 42 days.
Chickens (broilers and pullets): 12 days
Turkeys: 19 days
Not for use in birds producing eggs for human consumption.
Do not use within 2 weeks before the start of the laying period.
Not authorised for use in animals producing milk for human consumption.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.